Publications 2021

Seljelid B, Varsi C, Nes LS, Oystese KA, Borosund E (2021)
A Digital Patient-Provider Communication Intervention (InvolveMe): Qualitative Study on the Implementation Preparation Based on Identified Facilitators and Barriers
J. Med. Internet Res., 23 (4), e22399
DOI 10.2196/22399

Sjostedt E, Kolnes AJ, Olarescu NC, Mitsios N, Hikmet F, Sivertsson A, Lindskog C, Oystese KAB, Jorgensen AP, Bollerslev J, Casar-Borota O (2021)
TGFBR3L-An Uncharacterised Pituitary Specific Membrane Protein Detected in the Gonadotroph Cells in Non-Neoplastic and Tumour Tissue
Cancers, 13 (1), 114
DOI 10.3390/cancers13010114

Voll M, Oystese KA, Hoiskar E, Johansen O, Nyvold C, Norheim I, von Lueder TG, Andersen GO (2021)
Case report: a patient with thyroid storm, refractory cardiogenic shock, and cardiac arrest treated with Lugol's iodine solution and veno-arterial extra corporalmembrane oxygenation support
Eur. Heart J.-Case Rep., 5 (2), ytab017
DOI 10.1093/ehjcr/ytab017

Publications 2020

Eieland AK, Normann KR, Sundaram AYM, Nyman TA, Oystese KAB, Lekva T, Berg JP, Bollerslev J, Olarescu NC (2020)
Distinct Pattern of Endoplasmic Reticulum Protein Processing and Extracellular Matrix Proteins in Functioning and Silent Corticotroph Pituitary Adenomas
Cancers, 12 (10), 2980
DOI 10.3390/cancers12102980

Kolnes AJ, Oystese KA, Dahlberg D, Berg-Johnsen J, Niehusmann P, Pahnke J, Bollerslev J, Jorgensen AP (2020)
Cut-off values for sufficient cortisol response to low dose Short Synacthen Test after surgery for non-functioning pituitary adenoma
Acta Neurochir., 162 (4), 845-852
DOI 10.1007/s00701-019-04068-z

Kolnes AJ, Oystese KAB, Olarescu NC, Ringstad G, Berg-Johnsen J, Casar-Borota O, Bollerslev J, Jorgensen AP (2020)
FSH Levels Are Related to E-cadherin Expression and Subcellular Location in Nonfunctioning Pituitary Tumors
J. Clin. Endocrinol. Metab., 105 (8), 2587-2594
DOI 10.1210/clinem/dgaa281

Publications 2019

Oystese KAB, Hisanawi S, Zucknick M, Bollerslev J, Ringstad G (2019)
Are volume measurements of non-functioning pituitary adenomas reliable?
Endocrine, 63 (1), 171-176
DOI 10.1007/s12020-018-1752-8

Publications 2018

Falch CM, Sundaram AYM, Oystese KA, Normann KR, Lekva T, Silamikelis I, Eieland AK, Andersen M, Bollerslev J, Olarescu NC (2018)
Gene expression profiling of fast- and slow-growing non-functioning gonadotroph pituitary adenomas
Eur. J. Endocrinol., 178 (3), 295-307
DOI 10.1530/EJE-17-0702

Oystese KAB, Berg JP, Normann KR, Zucknick M, Casar-Borota O, Bollerslev J (2018)
The role of E and N-cadherin in the postoperative course of gonadotroph pituitary tumours
Endocrine, 62 (2), 351-360
DOI 10.1007/s12020-018-1679-0

Publications 2017

Oystese KA, Casar-Borota O, Normann KR, Zucknick M, Berg JP, Bollerslev J (2017)
Estrogen Receptor alpha, a Sex-Dependent Predictor of Aggressiveness in Nonfunctioning Pituitary Adenomas: SSTR and Sex Hormone Receptor Distribution in NFPA
J. Clin. Endocrinol. Metab., 102 (9), 3581-3590
DOI 10.1210/jc.2017-00792

Oystese KA, Zucknick M, Casar-Borota O, Ringstad G, Bollerslev J (2017)
Early postoperative growth in non-functioning pituitary adenomas; A tool to tailor safe follow-up
Endocrine, 57 (1), 35-45
DOI 10.1007/s12020-017-1314-5

Publications 2016

Casar-Borota O, Oystese KAB, Sundstrom M, Melchior L, Popovic V (2016)
A high-throughput analysis of the IDH1(R132H) protein expression in pituitary adenomas
Pituitary, 19 (4), 407-414
DOI 10.1007/s11102-016-0720-7

Normann KR, Oystese KAB, Berg JP, Lekva T, Berg-Johnsen J, Bollerslev J, Olarescu NC (2016)
Selection and validation of reliable reference genes for RT-qPCR analysis in a large cohort of pituitary adenomas
Mol. Cell. Endocrinol., 437 (C), 183-189
DOI 10.1016/j.mce.2016.08.030

Oystese KA, Evang JA, Bollerslev J (2016)
Non-functioning pituitary adenomas: growth and aggressiveness
Endocrine, 53 (1), 28-34
DOI 10.1007/s12020-016-0940-7

Publications 2011

Meland E, Gronhaug S, Oystese K, Mildestvedt T (2011)
Examining the Matthew effect on the motivation and ability to stay at work after heart disease
Scand. J. Public Health, 39 (5), 517-524
DOI 10.1177/1403494811399650